| | | Battling drug-resistant tuberculosis: New life for old treatments | | A new compound that boosts the efficacy of the tuberculosis drug ethianomide has successfully completed phase 1 clinical trials, thanks to IMI project TRIC-TB. | | |
|
| | | Reaching the desired (health) outcome | | IMI project H2O has launched its first health outcomes observatories, in the Netherlands, Spain and Austria. The observatories cover cancer, diabetes, and inflammatory bowel disease. | | |
|
|
|
|
|
|
|
|
|
